Research on the Mechanism of Ischemic Tolerance-Involvement in Caspase-

缺血耐受机制研究-Caspase参与-

基本信息

  • 批准号:
    12670624
  • 负责人:
  • 金额:
    $ 1.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Experimental study was done by using transient global ischemic model in gerbil. Adult male Mongolian gerbils were anesthetized with inhalation 1.5 % halothane. Global ischemia was induced by occluding bilateral common carotid arteries (BCCAs) by using aneurysm clip. The rectal and brain temperature was maintained at 36.5 to 37.5 ℃ with a heating blanket until the animals removed from surgery. Animals were divided into 4 groups. : Group I (Ischemic tolerance group) : Before 48 hours of 5 min ischemia, animal were occleded BCCAs for 2 min. Group II (Subrethal ischemic group) : Before 48 hours of sham operation, animal were occleded BCCAs for 2 min. Group III (Rethal ischemic group) : After 48 hours of sham operation, animal were occleded BCCAs for 5 min. Group IV (Sham operation group) : After 48 hours of sham operation, sham operation was done in this group. At the predetrmined reperfusion intervals, gerbils were anethetized and perfusion fixed with 10 ml heparinized phosphate-buffered … More saline followed by 60 ml 4 % paraformaldehyde buffered with 100 m mol/1 phosphate (pH 7, 4). The brains were removed, postfixed in 10 % formalin and paraffin embedded. Brain sections were collected at the level of middorsal hippocampus and stained for hematoxylin and eosin. Surviving CA1 neurinal cell counts from the left and right hipocampi were averaged and expressed as counts per millimeter for CA1. Animals in Group I (Ischemic tolerance group), were showed a significant increase in CA1 neurinal survival compared with those in Group III (Rethal ischemic group). DNA fragmentation by using TUNEL method, was found at 2 day after 5 min ischemia in Group III (Rethal ischemic group). Furthermore, immunocytochemistry with antibody against Caspase-3 was done by using Velier's method (Velier JJ, J Neurosci 19 : 5932-5941, 1999). Immunocytochemical analysis has not revealed Caspase-3 protein before inducing rethal ischemia. After 3, 6, 12, 24 hours of 5 min ischemia, Caspase-3 protein was also not induced in Group III (Rethal ischemic group). Immunocytochemical analysis in Group I (Ischemic tolerance group), revealed Caspase-3 protein after 2 days of 5 min ischemia, however that in Group III (Rethal ischemic group) did not reveal Caspase-3 protein at the same interval. Less
实验研究是通过在Gerbil中使用瞬态全球缺血模型完成的。成年男性蒙古沙鼠用吸入1.5%的氟烷麻醉。全局缺血是通过使用动脉瘤夹阻塞双侧普通颈动脉(BCCA)来诱导的。直肠和大脑温度保持在36.5至37.5℃,并用加热毯子保持在手术中。动物分为4组。 :I组(缺血性耐受性组):在48小时缺血48小时之前,将动物遮住了2分钟。 II组(下缺血组):在48小时操作之前,将动物遮住2分钟。 III组(复发性缺血组):在手术48小时后,将动物遮住了5分钟。第四组(假手术组):48小时的假手术后,该组进行了假手术。在预处理的再灌注间隔中,逐渐消除沙鼠并用10 ml甲基化磷酸盐缓冲固定……更多的盐水,然后用100 m mol/1 mol/1磷酸盐缓冲(pH 7,4)60 ml 4%多聚甲醛。将大脑移除,以10%的福尔马林和石蜡嵌入后固定。在中间海马的水平上收集脑部切片,并染色为苏木精和曙红。将从左右Hipocampi的CA1神经元细胞计数进行平均,并表示为CA1的每毫米计数。与III组(复发性缺血组)相比,I组(缺血性耐受性组)中的动物(缺血性耐受性组)显着增加。使用TUNEL方法在第III组5分钟缺血后2天发现了DNA碎片(复发性缺血组)。此外,使用Velier的方法(Velier JJ,J Neurosci 19:5932-5941,1999)进行了抗Caspase-3的免疫细胞化学化学。免疫细胞化学分析尚未揭示caspase-3蛋白在诱导再现缺血之前。在3、6、12、24小时的缺血5分钟后,在第三组(复位缺血组)中也未诱导caspase-3蛋白。第I组(缺血性)耐受性组的免疫细胞化学分析显示,在5分钟缺血2天后,CASPASE-3蛋白是caspase-3蛋白,但是在III组(复发性缺血组)中,并未在相同的间隔内揭示caspase-3蛋白。较少的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATAYAMA Yasuo其他文献

KATAYAMA Yasuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATAYAMA Yasuo', 18)}}的其他基金

Effect of combined treatment with transplantation of BMSCs and an neuroprotective agent,FK506 on enhancement of amelieration of ischemic brain damege.
BMSCs移植与神经保护剂FK506联合治疗对改善缺血性脑损伤的增强作用。
  • 批准号:
    20591011
  • 财政年份:
    2008
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of novel brain prothctants on neuroregeneration falbwing brain ischemia
新型脑保护剂对弱翼脑缺血神经再生的影响
  • 批准号:
    18590958
  • 财政年份:
    2006
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research on the Mechanism of Extra-mild Hypothermia(35℃) on neuronal cell death
超低温(35℃)对神经细胞死亡的机制研究
  • 批准号:
    16590851
  • 财政年份:
    2004
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research on the Mechanism of Neuroprotection of Mild Hypothermia (35℃)-Combination Therapy with Neuroprotective Agents-
亚低温(35℃)神经保护机制研究-神经保护剂联合治疗-
  • 批准号:
    14570624
  • 财政年份:
    2002
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Apopotosis Suppression in Ischemic Tolerance Phenomenon
缺血耐受现象中的细胞凋亡抑制
  • 批准号:
    10670609
  • 财政年份:
    1998
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ischemic tolerance phenomenon from an approach of energy metabolism
从能量代谢途径观察缺血耐受现象
  • 批准号:
    06454281
  • 财政年份:
    1994
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Cochlear synaptopathy after transient inner ear ischemia in gerbil
沙鼠短暂内耳缺血后的耳蜗突触病
  • 批准号:
    23K08913
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Vaccine for Lymphatic Filariasis, LFGuard™
淋巴丝虫病疫苗 LFGuard™
  • 批准号:
    10200657
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
A Vaccine for Lymphatic Filariasis, LFGuard™
淋巴丝虫病疫苗 LFGuard™
  • 批准号:
    10082074
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
A Vaccine for Lymphatic Filariasis, LFGuard™
淋巴丝虫病疫苗 LFGuard™
  • 批准号:
    10408790
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
Molecular Mechanisms of Neurogenesis and Roles of Newborn Cells in Gerbil Hippocampus after Transient Global Ischemia
短暂性全身缺血后沙鼠海马神经发生的分子机制和新生细胞的作用
  • 批准号:
    17K10846
  • 财政年份:
    2017
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了